PhII ICb With/Without Erbitux in MBC Pts

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

154

Participants

Timeline

Start Date

July 28, 2005

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Metastatic Breast Cancer
Interventions
DRUG

Irinotecan + Carboplatin

irinotecan 90 mg/m2 and carboplatin AUC=2.0 on Days 1 and 8 of each 21-day cycle

DRUG

irinotecan + Carboplatin + erbitux

irinotecan 90mg/m2, carboplatin AUC=2.0 on Days 1 and 8 of each 21- day cycle plus Erbitux 400 mg/m2

Trial Locations (59)

12148

New York Oncology Hematology, PC, Rexford

12208

New York Oncology Hematology, P.C., Albany

14623

Interlakes Oncology Hematology, PC, Rochester

21044

Maryland Oncology Hematology, P.A., Columbia

23505

Virginia Oncology Associates, Norfolk

24153

Onc and Hem Associates of SW VA, Inc., Salem

27511

Raleigh Hematology Oncology Clinic, Cary

29672

Cancer Center of the Carolinas, Seneca, Seneca

32901

Melbourne Internal Medicine Associates, Melbourne

34474

Ocala Oncology Center, Ocala

34655

Florida Cancer Institute, New Port Richey

34761

Cancer Centers of Florida, P.A., Ocoee

35205

Birmingham Hematology and Oncology, Birmingham

45409

Greater Dayton Cancer Center, Kettering

46227

Central Indiana Cancer Center, Indianapolis

55404

Minnesota Oncology Hematology, P.A., Minneapolis

60611

Hematology Oncology Associates of IL, Chicago

63141

Arch Medical Services, Inc, St Louis

65201

Missouri Cancer Associates, Columbia

66210

Kansas City Cancer-Southwest, Overland Park

75090

Texas Cancer Center-Sherman, Sherman

75150

Texas Cancer Center of Mesquite, Mesquite

75230

Texas Cancer Center at Medical City, Dallas

75231

Texas Oncology, P.A., Dallas

75237

The Texas Cancer Center, Dallas

75246

Texas Oncology, P.A., Dallas

75460

Paris Regional Cancer Center, Paris

75601

Longview Cancer Center, Longview

75702

Tyler Cancer Center, Tyler

76014

Texas Cancer Center, Arlington

76022

Texas Oncology, P.A. - Bedford, Bedford

76104

Texas Oncology, P.A., Fort Worth

76210

Texas Oncology Center - Denton, Denton

76712

Waco Cancer Care and Research Center, Waco

77024

Texas Oncology, P.A., Houston

77479

Texas Oncology Cancer Center-Sugar Land, Sugar Land

77702

Mamie McFaddin Ward Cancer Center, Beaumont

78131

HOAST - New Braunfels, New Braunfels

78503

South Texas Cancer Center-McAllen, McAllen

78624

San Antonio Tumor & Blood Clinic, Fredericksburg

78731

Texas Oncology Cancer Center, Austin

79606

Texas Cancer Center-Abilene(South), Abilene

79701

Allison Cancer Center, Midland

79761

West Texas Cancer Center, Odessa

79915

El Paso Cancer Treatment Ctr, El Paso

80220

Rocky Mountain Cancer Center-Rose, Denver

85012

Hematology Oncology Asscociates, Phoenix

86336

Northern AZ Hematology & Oncology Assoc, Sedona

89109

Comprehensive Cancer Centers of Nevada, Las Vegas

97401

Willamette Valley Cancer Center, Eugene

98026

Puget Sound Cancer Center-Emonds, Edmonds

98133

Puget Sound Cancer Center-Seattle, Seattle

98684

Northwest Cancer Specialists-Vancouver, Vancouver

98902

Yakima Valley Mem Hosp/North Star Lodge, Yakima

99202

Cancer Care Northwest-South, Spokane

06790

Northwestern Connecticut Oncology Hematology Associates, Torrington

03106

NH Oncology-Hematology PA, Hooksett

07960

Hematology-Oncology Associates of NNJ, P.A., Morristown

07901

Summit Medical Group, Summit

Sponsors
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

collaborator

Pfizer

INDUSTRY

lead

US Oncology Research

INDUSTRY